Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

A Phase 1b/3 Global, Randomized, Double-blind in Subjects With Double-blind, Randomized Controlled Study, With Advanced Epithelioid Sarcoma

A Phase 1b/3 Global, Randomized, Double-blind in Subjects With Double-blind, Randomized Controlled Study, With Advanced Epithelioid Sarcoma
Conditions:   Advanced Soft Tissue Sarcoma;   Advanced Epithelioid Sarcoma
Interventions:   Drug: Tazemetostat;   Drug: Placebo;   Drug: Doxorubicin HCl
Sponsor:   Epizyme, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 20, 2019 / by / in
Comments